Catalyst Wire Dossier Catalyst Wire Dossier

Vaniqa

eflornithine · Almirall, S.A.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Vaniqa, covering 2024-11-27 to 2024-11-27. Get the full timeline:

Most recent: EMA Authorised: Vaniqa (eflornithine) — Almirall, S.A.

See pricing